IEET > Rights > HealthLongevity > Arthur Caplan > Innovation > ReproRights
Plan B ruling trumps good science with bad policy
Arthur Caplan   Dec 11, 2011   MSNBC  

The morning-after pill known as Plan B is steeped in controversy again. The Department of Health and Human Services has taken the rare step of overruling the Food and Drug Administration and its science advisors and will not allow the pill to be sold over the counter in drugstores unless a woman can prove she is older than 17.

The stunning override of the FDA is bad public policy.  This is a case of politics triumphing over science yet again when it comes to matters of reproduction, contraception and abortion in the U.S.

Plan B has stirred strong emotions from the minute its manufacturer sought FDA approval. During the Bush administration, abortion foes tried to stifle the drug on the grounds that it works as an abortion agent even though the drug actually prevents a fertilized egg from implanting in the womb, which is not in the scientific sense of the term an abortion. Some docs and pharmacists made headlines by saying they would not prescribe the pill even in the case of a rape.  Some hospitals will not stock it.

Read the rest here

Arthur L. Caplan, Ph.D., is the Drs. William F and Virginia Connolly Mitty Professor and head of the Division of Bioethics at New York University Langone Medical Center in New York City.



COMMENTS

This is very good news sire!
But, what if, if the mother ask her daughter to do so because her mother was seek and no one else is around only her daughter.?

YOUR COMMENT Login or Register to post a comment.

Next entry: An End of Year Appeal for Support

Previous entry: Hughes and Blackford featured in Free Inquiry